Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

计划入组 17 人 · 首次发布于 2009 年 5 月 18 日

Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer

计划入组 3,832 人 · 首次发布于 2024 年 1 月 25 日

Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

计划入组 1,000 人 · 首次发布于 2020 年 7 月 20 日

LVP Extended-release therapy(Huahai Pharmaceutical)

Baclofen Extended Release

Endocrine Target(Agonist)(septerna)

Endocrine Research Society

Canada

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

Hologic's Breast Cancer Index Test Demonstrates Significant Impact on Extended Endocrine Therapy Decisions in Real-World Study

MammaPrint Assay Identifies Subgroup Benefiting from Extended Letrozole Therapy in Early-Stage Breast Cancer

Breast Cancer Index Test Shows Promise for Identifying Low-Risk Premenopausal Patients Who May Avoid Aggressive Therapy